{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:37:30Z","timestamp":1789792650039,"version":"4.0.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"WPU"},{"name":"Luye Pharma Group"},{"name":"WPU"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jacl.2014.09.002","type":"journal-article","created":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:51:24Z","timestamp":1410828684000},"page":"568-575","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study"],"prefix":"10.1016","volume":"8","author":[{"given":"Patrick M.","family":"Moriarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli M.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Karns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Capuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold E.","family":"Bays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osvaldo A.","family":"Brusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping Lan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2014.09.002_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.165.3.281","article-title":"Recent trends in use of herbal and other natural products","volume":"165","author":"Kelly","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ctim.2012.07.004","article-title":"The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders","volume":"20","author":"Yang","year":"2012","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1749-8546-1-4","article-title":"Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials","volume":"1","author":"Liu","year":"2006","journal-title":"Chin Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cccn.2004.09.026","article-title":"Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina","volume":"352","author":"Li","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacl.2014.09.002_bib5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijcard.2011.11.005","article-title":"Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS)","volume":"154","author":"Li","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3109\/10641961003686427","article-title":"Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS)","volume":"32","author":"Li","year":"2010","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.jacl.2014.09.002_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","article-title":"HypoCol (red yeast rice) lowers plasma cholesterol: a randomized placebo controlled study","volume":"44","author":"Bogsrud","year":"2010","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.jacl.2014.09.002_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/07853891003652534","article-title":"Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)","volume":"42","author":"Li","year":"2010","journal-title":"Ann Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib9","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/FJC.0b013e31802d3a58","article-title":"Xuezhikang, an extract of cholestin, reduces cardiovascular events in type 2 diabetes patients with coronary heart disease: subgroup analysis of patients with type 2 diabetes from China Coronary Secondary Prevention Study (CCSPS)","volume":"49","author":"Zhao","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jacl.2014.09.002_bib11","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2006.11.031","article-title":"Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improves exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X","volume":"122","author":"Li","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10557-006-7947-x","article-title":"Effects of withdrawal of Xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with coronary artery disease","volume":"20","author":"Hu","year":"2006","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacl.2014.09.002_bib13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","article-title":"Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia","volume":"153","author":"Lin","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jacl.2014.09.002_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9150(03)00142-4","article-title":"Effect of xuezhikang, a cholestin extract, on reflecting postprandial triglyceridemia after a high-fat meal in patients with coronary heart disease","volume":"168","author":"Zhao","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2014.09.002_bib15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/clc.4960240610","article-title":"Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia","volume":"24","author":"Davidson","year":"2001","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1161\/01.CIR.101.2.207","article-title":"Current perspectives on statins","volume":"101","author":"Maron","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2014.09.002_bib17","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0002-9149(97)00965-X","article-title":"Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)","volume":"81","author":"Jones","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2014.09.002_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijpharm.2013.01.028","article-title":"Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products","volume":"444","author":"Chen","year":"2013","journal-title":"Int J\u00a0Pharm"},{"key":"10.1016\/j.jacl.2014.09.002_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1089\/acm.2005.11.1031","article-title":"Plasma clearance of lovastatin versus Chinese red yeast rice in healthy volunteers","volume":"11","author":"Li","year":"2005","journal-title":"J Altern Complement Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib21","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacl.2014.09.002_bib22","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2014.09.002_bib23","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"issue":"25 Suppl 2","key":"10.1016\/j.jacl.2014.09.002_bib24","first-page":"S1","article-title":"2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741400316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193328741400316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:34:10Z","timestamp":1761831250000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193328741400316X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S193328741400316X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2014.09.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2014.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}